IL6 receptor³⁵⁸Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis

In the article “IL6 receptor³⁵⁸Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis” by Wosiski-Kuhn et al.,¹ first published online October 14, 2019, the y-axis label in figure 1C should be “Serum sIL6R (ng/mL).” In figure 1E, the y-axis label should be “Serum sgp130 (ng/mL).” In figure 2A, the y-axis label should be “Serum sIL6R (ng/mL).” The editorial office regrets the errors.